It should be noted that mechanical thrombectomy devices have failed to produce such benefits. Despite the encouraging results of the TAPAS trial and a few meta-analyses, a skepticism regarding the ...
Resource use and health outcomes with Penumbra’s tech were pitted against standard procedures such as anticoagulation, ...
Although the device is used in the West, AIIMS is testing a version that’s more suited to Indians and is cost-effective ...
In essence, all of these devices are used to decrease the time taken for thrombus removal and possibly to reduce the risk of prolonged infusion (Box 1). Percutaneous mechanical thrombectomy (PMT ...
In a report released today, Larry Biegelsen from Wells Fargo upgraded Penumbra (PEN – Research Report) to a Buy, with a price target of ...
Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other vascular diseases, announced today ...